U.S. Food and Drug Administration
Duke-Margolis brings together external experts, the university’s leading research, education, and engagement capabilities, and the broader public to inform policymaking and the advancement of regulatory science at the U.S. Food and Drug Administration.
Projects Relating to U.S. Food and Drug Administration
Duke-Margolis Faculty & Research Team
Adam Aten, MPH, MSc
Research Associate
Nicholas Harrison, MPH, MA
Senior Policy Analyst
Adam Kroetsch, MPP
Research Director, Biomedical Innovation and Regulatory Policy
Senior Team Member
Nirosha Mahendraratnam Lederer, PhD, MSPH
Managing Associate, Real World Evidence
Senior Team Member
2020 Intern Mentor
Mark McClellan, MD, PhD
Director of Margolis Center
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty
Thomas Roades, MPP
Policy Analyst
Morgan Romine, MPA
Chief of Staff
Senior Team Member
Sarah Sheehan, MPA
Managing Associate
Senior Team Member
Kelly Wahl, MPH
Research Associate
Marta Wosińska, PhD
Deputy Director, Policy, Duke-Margolis Center for Health Policy
Margolis Core Faculty
Consulting Professor, Duke-Margolis Center for Health Policy
Press Release July 23, 2019
Press Release: A Path For FDA, Consumers Toward More Effective Drug Safety Labeling
WASHINGTON, D.C. -- Changes by the Food and Drug Administration (FDA) to drug safety labeling are an...
Read More
News Update January 7, 2019
Former Commissioners Call for FDA to Become Independent Federal Agency
In a commentary published in Health Affairs, seven former FDA Commissioners call for the FDA to...
Read MoreNews Update November 29, 2018
The FDA Sentinel Initiative — An Evolving National Resource
Duke-Margolis Center Director Mark McCellan, MD, PhD, co-authored a New England Journal of Medicine...
Read More